中文速读
针对急性髓系白血病,使用HL60、K562细胞和AML患者新鲜骨髓单个核细胞,通过Entranster-R4000转染siRNA敲低SLC22A3,发现促进细胞增殖、抑制凋亡,表明SLC22A3甲基化沉默与不良预后相关。
体外(细胞)siRNAHL60K562AML fresh BMMNCs
SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia
Affiliations
- 1 Department of Hematology, Affiliated People’s Hospital of Jiangsu University, 8 Dianli Rd., Zhenjiang, 212002, Jiangsu, People’s Republic of China.
- 2 Zhenjiang Clinical Research Center of Hematology, 8 Dianli Rd., Zhenjiang, 212002, Jiangsu, People’s Republic of China.
- 3 The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People’s Republic of China.
- 4 Laboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China.
- 5 Zhenjiang Clinical Research Center of Hematology, 8 Dianli Rd., Zhenjiang, 212002, Jiangsu, People’s Republic of China. 2651329493@qq.com.
- 6 Laboratory Center, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu, People’s Republic of China. 2651329493@qq.com.
- 7 The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People’s Republic of China. 2651329493@qq.com.
- 8 Department of Hematology, Affiliated People’s Hospital of Jiangsu University, 8 Dianli Rd., Zhenjiang, 212002, Jiangsu, People’s Republic of China. qianjun0007@hotmail.com.
- 9 Zhenjiang Clinical Research Center of Hematology, 8 Dianli Rd., Zhenjiang, 212002, Jiangsu, People’s Republic of China. qianjun0007@hotmail.com.
- 10 The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City, Zhenjiang, Jiangsu, People’s Republic of China. qianjun0007@hotmail.com.
- PMID: 36461046
- PMCID: PMC9716704
- DOI: 10.1186/s13148-022-01373-w
Abstract
Background: We screened out several hypermethylated solute carrier (SLC) family genes in acute myeloid leukemia by reduced representation bisulfite sequencing. SLC22A3 encodes an organic cation transport protein, which is critical for drug transportation and cellular detoxification. SLC22A3 is significantly downregulated and associated with tumor progression and worse prognosis in a variety of solid tumors. However, there are no data available regarding the role of SLC22 in AML. This study aimed to explore the regulatory mechanism of DNA methylation on SLC22A3 expression, as well as its clinical significance in AML prognosis.
Results: SLC22A3 was identified as the sole prognosis-associated gene among SLCs based on TCGA and Beat AML databases. Bone marrow mononuclear cells (BMMNCs) from AML, MDS patients, and healthy donors were enrolled in this study. SLC22A3 methylation was significantly increased in AML compared with controls and MDS patients; meanwhile, the expression level of SLC22A3 was decreased. SLC22A3 hypermethylation presented an obvious association with some specific clinical characteristics and affected the survival time of AML patients as an independent risk indicator. SLC22A3 expression changed regularly as the disease complete remissions and relapses. Demethylation drug 5-aza-2′-deoxycytidine (DAC) activated transcription and increased mRNA expression of SLC22A3 in leukemia cell lines and AML fresh BMMNCs. Knockdown of SLC22A3 in leukemia cells enhanced cell proliferation and suppressed cell apoptosis. Data from public programs were used for auxiliary screening of probable molecular mechanisms of SLC22A3 in the antileukemia effect.
Conclusions: Our results showed that increased methylation and decreased expression of SLC22A3 may be indicators of poor prognosis in AML. Methylation-silenced SLC22A3 expression may have potential guiding significance on antileukemia effect of DAC.
Keywords: 5-aza-2′-deoxycytidine; Acute myeloid leukemia; Methylation; SLC22A3.
小核酸转染试剂Entranster™-R4000 已有 223 篇已发表文献
同类研究
- J Ovarian Res. 2026 Jul 31;19(1):330.doi: 10.1186/s13048-026-02215-6. Microfluidic lipid nanoparticles co-delivering siM…
- Front Immunol. 2026 May 29;17:1724930.doi: 10.3389/fimmu.2026.1724930. Machine learning-based identification of an oxida…
- Cell Calcium. 2026 Apr 19:135:103137.doi: 10.1016/j.ceca.2026.103137. TRPC1 channel modulates mechanical stretch-induced…
- Pharmaceuticals (Basel). 2026 Mar 27;19(4):540.doi: 10.3390/ph19040540. Identification of Dopamine D2 Receptor as a Dire…
- Viruses. 2026 Mar 5;18(3):323.doi: 10.3390/v18030323. Tree Shrew Genome-Wide CRISPR Screen Identifies RNF6 as a Proviral…